【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份

中金财经05-22

　　证券之星消息，5月21日，港股通创新药ETF汇添富基金(159570)涨2.24%，成交额28.33亿元。当日份额减少了1.88亿份，最新份额为186.31亿份，近20个交易日份额增加6.13亿份。当日资金净流入1.1亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为265.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立(2023-12-28)以来超额回报为-3.97%，近一个月超额回报为1.4%，管理人为汇添富基金公司，基金经理为乐无穹。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2637366330?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-05-22 08:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2637366330","market":"sh","top_or_hot":-1,"title":"【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份","media":"中金财经","content":"<html><body><p>　　证券之星消息，5月21日，港股通创新药ETF汇添富基金(159570)涨2.24%，成交额28.33亿元。当日份额减少了1.88亿份，最新份额为186.31亿份，近20个交易日份额增加6.13亿份。当日资金净流入1.1亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为265.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立(2023-12-28)以来超额回报为-3.97%，近一个月超额回报为1.4%，管理人为汇添富基金公司，基金经理为乐无穹。 </p></body></html>","source":"zhongjincaijing_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【ETF动向】5月21日港股通创新药ETF汇添富基金涨2.24%，份额减少1.88亿份\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><p>　　证券之星消息，5月21日，港股通创新药ETF汇添富基金(159570)涨2.24%，成交额28.33亿元。当日份额减少了1.88亿份，最新份额为186.31亿份，近20个交易日份额增加6.13亿份。当日资金净流入1.1亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为265.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立(2023-12-28)以来超额回报为-3.97%，近一个月超额回报为1.4%，管理人为汇添富基金公司，基金经理为乐无穹。 </p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://sc.stock.cnfol.com/gushiyaowen/20260522/32245715.shtml\">中金财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FDN","symbol_name":"First Trust Dow Jones Internet I","start_time":0,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260522/32245715.shtml","article_id":"2637366330","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2637366330","pubTimestamp":1779410900,"columns":[],"sourceInfo":{"source_id":"zhongjincaijing_highlight","name":"中金在线"},"weMediaInfo":null,"summary":"证券之星消息，5月21日，港股通创新药ETF汇添富基金(159570)涨2.24%，成交额28.33亿元。当日份额减少了1.88亿份，最新份额为186.31亿份，近20个交易日份额增加6.13亿份。当日资金净流入1.1亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为265.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立(2023-12-28)以来超额回报为-3.97%，近一个月超额回报为1.4%，管理人为汇添富基金公司，基金经理为乐无穹。","collect":0,"end_time":0,"defaultTopTitle":"cnfol.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159316":"创新药E","FDN":"First Trust Dow Jones Internet I","BK4585":"ETF&股票定投概念","VXUS":"国际股票ETF-Vanguard","BK4588":"碎股","BK4550":"红杉资本持仓"},"translate_title":"[ETF Trends] On May 21, Hong Kong Stock Connect Innovative Drug ETF China Universal Fund rose 2.24%, and its share decreased by 188 million shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159316":1.5,"VXUS":1.5,"FDN":1.5},"content_text":"证券之星消息，5月21日，港股通创新药ETF汇添富基金(159570)涨2.24%，成交额28.33亿元。当日份额减少了1.88亿份，最新份额为186.31亿份，近20个交易日份额增加6.13亿份。当日资金净流入1.1亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的)，最新资产净值计算值为265.75亿元。港股通创新药ETF汇添富基金跟踪标的为国证港股通创新药指数，成立(2023-12-28)以来超额回报为-3.97%，近一个月超额回报为1.4%，管理人为汇添富基金公司，基金经理为乐无穹。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2637366330","isCrawlerRequest":true}